PIONEER Big Data Platform
The PIONEER Big Data Platform offers a central and federated state-of-the-art Big Data analytic platform for prostate cancer. The platforms anonymous data is harmonised to the European Common Data Model, OMOP-CDM, following all legal and ethical requirements. The PIONEER Big Data platform brings together diverse datasets, contributed by our Partners and Associated Members, including the pharmaceutical industry, hospital electronic health records, large registry studies and interventional, and non-interventional trials.
The PIONEER Big Data platform is about building an open and transparent infrastructure that enables a collaborative research environment to improve prostate cancer care for patients and their families focusing on: prostate cancer-related outcomes; health system efficiency; and the quality of health and social care across Europe.
PIONEER will make a meaningful contribution towards improved patient stratification, and improved identification of low- and high-risk patients, including which patients are more likely to respond to a specific treatment. PIONEER’s results will improve evidence-based shared decision-making for all prostate cancer patients, ultimately minimising inequalities between all European prostate cancer patients through the standardisation of care pathways across Europe.
The PIONEER Big Data Platform for Prostate Cancer is a unique infrastructure in Europe that enables a collaborative research
environment to improve prostate cancer diagnosis, treatment, and care for patients and their families.
Read all about it at: PIONEER Big Data Platform
PIONEER Big Data Platform explainer
Dr. Bertrand De Meulder and Dr. Michaell Bussmann explains what the PIONEER Big Data Platform is, and how it can be used to further prostate cancer research.
